Size of myocardial infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome

被引:26
作者
Thim, T [1 ]
Bentzon, JF
Kristiansen, SB
Simonsen, U
Andersen, HL
Wassermann, K
Falk, E
机构
[1] Aarhus Univ Hosp Skejby, Dept Cardiol, Aarhus, Denmark
[2] Aarhus Univ Hosp Skejby, Inst Clin Med, Aarhus, Denmark
关键词
diabetes mellitus; diet; ischaemia/reperfusion injury; metabolic syndrome; myocardial infarction; obesity;
D O I
10.1042/CS20050326
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Obesity is associated with metabolic syndrome and increased incidence of and mortality from myocardial infarction. The aim of the present study was to develop an animal model with metabolic syndrome and examine how that influences size of myocardial infarcts induced by occlusion and reperfusion of the left anterior descending coronary artery. Sprague-Dawley rats (n = 105) were fed either LF (low-fat) or MHF (moderately high-fat) diets for 13 weeks before coronary occlusion for 45 min, followed by reperfusion for 60 min. Compared with LF-fed and lean MHF-fed rats, obese MHF-fed rats developed metabolic disturbances similar to those seen in the metabolic syndrome, including being overweight by 24% (compared with lean MHF-fed rats), having 74% more visceral fat (compared with LF-fed rats), 15% higher blood pressure (compared with LF-fed rats), 116% higher plasma insulin (compared with lean MHF-fed rats), 10% higher fasting plasma glucose (compared with LF-fed rats), 35% higher non-fasting plasma glucose (compared with lean MHF-fed rats), 36% higher plasma leptin (compared with lean MHF-fed rats) and a tendency to lower plasma adiponectin and higher plasma non-esterified fatty acids. Infarct size was similar in the three groups of rats (36 +/- 14, 42 +/- 18 and 41 +/- 14% in obese MHF-fed, lean MHF-fed and LF-fed rats respectively). In conclusion, rats fed a MHF diet developed metabolic syndrome, but this did not influence myocardial infarct size.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 35 条
[1]   Diabetes as a risk factor for sudden death [J].
Balkau, B ;
Jouven, X ;
Ducimetière, P ;
Eschwège, E .
LANCET, 1999, 354 (9194) :1968-1969
[2]   Surgical removal of visceral fat reverses hepatic insulin resistance [J].
Barzilai, N ;
She, L ;
Liu, BQ ;
Vuguin, P ;
Cohen, P ;
Wang, JL ;
Rossetti, L .
DIABETES, 1999, 48 (01) :94-98
[3]   Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes [J].
Behar, S ;
Boyko, V ;
ReicherReiss, H ;
Goldbourt, U .
AMERICAN HEART JOURNAL, 1997, 133 (03) :290-296
[4]   The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis [J].
Burns, RJ ;
Gibbons, RJ ;
Yi, QL ;
Roberts, RS ;
Miller, TD ;
Schaer, GL ;
Anderson, JL ;
Yusuf, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (01) :30-36
[5]   Pathogenesis of the insulin resistance syndrome (Syndrome X) [J].
Chisholm, DJ ;
Campbell, LV ;
Kraegen, EW .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) :782-784
[6]   Development of hypertension in a rat model of diet-induced obesity [J].
Dobrian, AD ;
Davies, MJ ;
Prewitt, RL ;
Lauterio, TJ .
HYPERTENSION, 2000, 35 (04) :1009-1015
[7]   Insulin resistance and cardiovascular disease [J].
Ginsberg, HN .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04) :453-458
[8]   Diabetes and cardiovascular disease - A statement for healthcare professionals from the American Heart Association [J].
Grundy, SM ;
Benjamin, IJ ;
Burke, GL ;
Chait, A ;
Eckel, RH ;
Howard, BV ;
Mitch, W ;
Smith, SC ;
Sowers, JR .
CIRCULATION, 1999, 100 (10) :1134-1146
[9]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752
[10]   Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats [J].
Hogarth, CA ;
Roy, A ;
Ebert, DL .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2003, 135 (02) :219-229